A carregar...
Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer
This phase II trial assessed the toxicity and efficacy of irinotecan plus docetaxel in cisplatin-pretreated oesophageal cancer. Irinotecan 160 mg m(−2) plus docetaxel 65 mg m(−2) once every 3 weeks led to severe myelosuppression in four patients, all of whom experienced neutropenic fever. After amen...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376928/ https://ncbi.nlm.nih.gov/pubmed/12915869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601168 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|